Friday, July 10, 2026

pharma · Invasive Extraintestinal Pathogenic Escherichia coli Disease · HIV-1 Infection

Zhejiang Xianju Pharmaceutical

News and analysis for Zhejiang Xianju Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

西安, CN HQ
146 Employees
NMPA registrant Type
Company details
Status
Public
HQ
西安, CN
Employees
146
Programs
2
Drugs
5
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Zhejiang Xianju Pharmaceutical — regulatory, clinical, and market coverage.

News and analysis for Zhejiang Xianju Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Zhejiang Xianju Pharmaceutical yet.

Back to company overview →